about
Trends in influenza vaccination behaviours--results from the CoPanFlu cohort, France, 2006 to 2011.Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.Planning for the next influenza H1N1 season: a modelling study.Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.Mortality risk among children admitted in a large-scale nutritional program in Niger, 2006.Prognostic accuracy of WHO growth standards to predict mortality in a large-scale nutritional program in Niger.Assessing assay agreement estimation for multiple left-censored data: a multiple imputation approach.Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.Pentoxifylline in heart failure: a meta-analysis of clinical trials.Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial.Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.Current cholera epidemics in west Africa and risks of imported cases in European countries.Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study.[The use of administrative health databases in infectious disease epidemiology and public health].[Imported cases of dengue fever diagnosed in metropolitan France, from January 2001 to December 2006].Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?WTW--an algorithm for identifying "who transmits to whom" in outbreaks of interhuman transmitted infectious agents.Acute kidney injury in adults with hemophagocytic lymphohistiocytosis.Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.[The concerning attitudes and beliefs of nursing students toward antidepressants and depression].Ethical issues arising from the requirement to provide written information in palliative careSignal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infectionMinimally invasive drainage in critically ill patients with severe necrotizing pancreatitis is associated with better outcomes: an observational studyPrediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessmentPharmacists' role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre studyBiased and unbiased estimation of the average lengths of stay in intensive care units in the COVID-19 pandemic
P50
Q30355606-AA2A8DAA-B334-4A96-A4F8-FAA88935A703Q30393540-82C41DF4-9E35-47D8-ABCD-B3C746DBFA98Q30395122-3DB05E03-A18A-40BA-B6BA-6B61F09CC4F4Q30407929-775B0CAE-703A-47C6-AA18-C30F40E99EE7Q30417707-4A75E802-BCF5-4C6C-9F49-FD2866EF2856Q33403750-AD492BDD-1EC8-4D3C-BB4B-BCC32E579837Q33414805-F336058B-7EB8-4F42-B7C5-AA57010A263EQ35310570-BDB49365-09BD-4954-B053-523B56CD0CF1Q36165309-65F2E740-78C2-4824-B936-E8BD0B047A52Q38206557-0495398A-37F3-41BC-9B20-C0337F9CD235Q38372180-9ABF1D5F-D03E-416D-B4CA-CA246F150ECCQ39324465-586EFCA0-E0C7-4283-8F1A-FF6DE0D27AE0Q39511539-B0E39CCC-F729-40E6-A417-2E07CF904D43Q40096391-EB18BDAD-A15F-4CD9-BAC5-7CA025665532Q40156316-9B05FEB9-89B2-4628-B1A0-60802384DFB0Q40406360-83191D92-A3D1-463E-8DAA-1E6876C91BE9Q40486811-D53E3CAE-569E-4FE9-8639-360F8792DDE1Q41313948-04F87647-C12B-496C-B599-9290B970DC09Q41614330-E2E4532B-A37B-4D29-8068-B75A59852508Q44005981-D79BDD2E-4747-4C81-AF43-CBBEDAD5D326Q45394175-FDD05619-6E4F-47AC-8665-6C1D06F30AC5Q45397390-D160E4DC-9EEA-4F4C-9CF6-B88D5B801012Q47244577-C8002452-6BC6-4FBE-A40B-43B6FADABCF4Q49609474-3AF73E44-D8CC-43D5-B9AC-352FCDB80983Q56786584-4BB4F4D1-BDEC-443F-9AD9-7046B1431242Q56833754-82042D37-6CA8-4C0B-9CB5-200F22723603Q59336106-CFB8275D-57F8-41E5-9542-5AAC706088F0Q85115297-0F444B3B-F61D-430F-81DA-947DAB46EC80Q92024021-E95E64B8-A168-4330-83E2-99F1AD29C780Q95600760-9F7B3738-F4DB-4221-9751-5E80CCA94FFC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
N Lapidus
@ast
N Lapidus
@en
N Lapidus
@es
N Lapidus
@nl
type
label
N Lapidus
@ast
N Lapidus
@en
N Lapidus
@es
N Lapidus
@nl
prefLabel
N Lapidus
@ast
N Lapidus
@en
N Lapidus
@es
N Lapidus
@nl
P106
P1153
23667904700
P31
P496
0000-0002-4837-1068